IP Library Granted Patent US 9,187,783
Granted Patent B2
US 9,187,783 · App. 13/824,129 · Granted Nov 17, 2015

Systems and methods for automated reusable parallel biological reactions

Inventors: Hesaam Esfandyarpour (Los Altos, CA); Mark F. Oldham (Emerald Hills, CA); Eric S. Nordman (Palo Alto, CA); Kosar Baghbani Parizi (Los Altos, CA)
Assignee: GENAPSYS, INC.
C12Q1/6869C12Q1/6848C12Q1/6853C12Q1/6874G01N27/4145G01N27/4146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,187,783
App. No.
13/824,129
Granted
Nov 17, 2015
Kind
B2
Abstract

A method comprises magnetically holding a bead carrying biological material (e.g., nucleic acid, which may be in the form of DNA fragments or amplified DNA) in a specific location of a substrate, and applying an electric field local to the bead to isolate the biological material or products or byproducts of reactions of the biological material. For example, the bead is isolated from other beads having associated biological material. The electric field in various embodiments concentrates reagents for an amplification or sequencing reaction, and/or concentrates and isolates detectable reaction by-products. For example, by isolating nucleic acids around individual beads, the electric field can allow for clonal amplification, as an alternative to emulsion PCR. In other embodiments, the electric field isolates a nanosensor proximate to the bead, to facilitate detection of at least one of local pH change, local conductivity change, local charge concentration change and local heat. The beads may be trapped in the form of an array of localized magnetic field regions.

Claims (27)

1. A method for sequencing, comprising:

(a) providing a plurality of particles, wherein each particle of said plurality is coupled to on average at most one nucleic acid molecule;

(b) performing simultaneous nucleic acid amplification reactions on said nucleic acid molecules coupled to said particles, wherein said nucleic acid amplification reactions are performed while subjecting the particles to an electric field, thereby producing isolated, clonally-amplified nucleic acid molecules coupled to said plurality of particles;

(c) performing nucleic acid extension reactions on said clonally-amplified nucleic acid molecules using primers that hybridize to said clonally-amplified nucleic acid molecules; and

(d) detecting nucleic acid incorporation events from said extension reactions using a sensor array to determine a sequence of each of said clonally-amplified nucleic acid molecules, wherein each particle of said plurality of particles is adjacent to a sensor of said sensor array, and wherein each said sensor of said sensor array comprises two electrodes that are within a Debye length of their respective individual particle or within a Debye length of a nucleic acid molecule on said individual particle.

2. The method of claim 1 , wherein said nucleic acid amplification reactions are emulsion free.

3. The method of claim 1 , further comprising, subsequent to (b), separating particles carrying clonally-amplified nucleic acid molecules from particles not carrying clonally-amplified nucleic acid molecules.

4. The method of claim 1 , wherein (b) is performed with the plurality of particles held adjacent to the sensor array.

5. The method of claim 1 , wherein, in (c), the particles are at least one of electrically and magnetically immobilized.

6. The method of claim 1 , further comprising releasing one or more of said plurality of particles.

7. The method of claim 1 , wherein, in (d), detecting said nucleic acid incorporation events further comprises using an individual sensor among the plurality of sensors to detect at least one of local impedance change and local conductivity change.

8. The method of claim 1 , wherein the electric field isolates or concentrates one or more of template DNA fragments, primers, polymerase, and dNTPs around each of the particles.

9. The method of claim 1 , wherein the electric field isolates or concentrates products of nucleic acid amplification reactions.

10. A method for nucleic acid sequencing, comprising:

(a) directing a plurality of particles onto an array of sensors, wherein an individual particle comprises a nucleic acid molecule, and wherein an individual sensor of said array comprises a pair of electrodes that are electrically coupled to a Debye length of said individual particle during nucleic acid sequencing;

(b) positioning said individual particle at said individual sensor;

(c) directing a plurality of primers onto said array;

(d) performing a primer extension reaction at said individual sensor; and

(e) during or subsequent to performing said primer extension reaction, measuring a change in impedance of said individual particle with the aid of said pair of electrodes that are each electrically coupled to said Debye length of said individual particle.

11. The method of claim 10 , further comprising amplifying said nucleic acid molecule prior to (d).

12. The method of claim 11 , wherein said nucleic acid molecule is amplified while subjecting said individual particle to an electric field.

13. The method of claim 11 , wherein said nucleic acid molecule is amplified while said individual particle is held at said given sensor.

14. The method of claim 1 , wherein an individual electrode of said two electrodes has a Debye length.

15. The method of claim 14 , wherein said Debye length of said individual electrode is within said Debye length of said individual particle or said Debye length of said nucleic acid molecule on said individual particle.

16. The method of claim 10 , wherein, in (e), the electrodes of said pair of electrodes are within said Debye length of said individual particle.

17. The method of claim 16 , wherein an individual electrode of said pair of electrodes has a Debye length.

18. The method of claim 17 , wherein said Debye length of said individual electrode is within said Debye length of said individual particle.

Assignments (10)
SECURITY INTEREST Recorded Jun 30, 2023
From: SEQUENCING HEALTH, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 064180/0928 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2022
From: GENAPSYS, INC.
To: SEQUENCING HEALTH, INC.
Reel/Frame 062128/0440 →
RELEASE OF SECURITY INTEREST Recorded Jan 26, 2021
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: GENAPSYS, INC.
Reel/Frame 055107/0633 →
SECURITY INTEREST Recorded Jun 25, 2020
From: GENAPSYS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 053053/0088 →
RELEASE OF SECURITY INTEREST Recorded Jul 17, 2019
From: OXFORD FINANCE LLC
To: GENAPSYS, INC.
Reel/Frame 049782/0910 →
SECURITY INTEREST Recorded Feb 6, 2019
From: GENAPSYS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 048257/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2013
From: ESFANDYARPOUR, HESAAM; PARIZI, KOSAR B.
To: GENAPSYS, INC.
Reel/Frame 031636/0721 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2013
From: NORDMAN, ERIC S.
To: GENAPSYS, INC.
Reel/Frame 031597/0209 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2013
From: OLDHAM, MARK F.
To: GENAPSYS, INC.
Reel/Frame 031415/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2013
From: ESFANDYARPOUR, HESAAM; PARIZI, KOSAR BAGHBANI; NORDMAN, ERIC S.; OLDHAM, MARK F.
To: GENAPSYS, INC.
Reel/Frame 030903/0664 →
Continuity (5)
Provisional Application 61389490 · Oct 4, 2010
Provisional Application 61389484 · Oct 4, 2010
Provisional Application 61443167 · Feb 15, 2011
Provisional Application 61491081 · May 27, 2011
Related Publication 20140045701A1 · Feb 13, 2014